The Effectiveness of Therapeutic Barium Enema for Prevention of Colonic Diverticular Rebleeding - Randomized Control study

Phase 3

• Conditions: colonic diverticular bleeding

• Registration Number: JPRN-UMIN000002832
• Lead Sponsor: International Medical Center of Japan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-12-02
• Study Completion: 2012-01-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

Patient informations are as follows 1.Patients who does not provide consent 2.Patients who was diagnosed with other intestinal bleeding such as colon cancer, hemorroids with bleeding, upper gastrointestinal bleeding, and small-bowel bleeding 3.Patients with little improvement of hemostasis by initial therapy 4.Patients with hemorrhagic shock or with suspected hemorrhagic shock 5.Patients with allergic reaction to contrast dye incuding CT and barium examination 6.Patients with suspected intestinal obstruction on the X-ray 7.Patients with a history of barium therapy within 6 months 8.Patients with terminal cancer 9.Patients with difficulty in changing body position 10.Patients with suspected pregnancy 11.Patients with a history of colon resection 12.Patients with already revealed intestinal cancer 13.Patients with diagnosis of imflammatory bowel disease(IBD)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The rate and period until diverticular rebleeding after the treatment with barium and conservative therapy

Secondary Outcome Measures

Name	Time	Method
clinical data between rebleeding and non-rebleeding patients: age, sex, underlying disease, history of medication, and volume of transfusion. clical data on barium therapy: the finding of X-ray, examination time, and complication.